Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 tesla

Molecular Imaging

Volumn 11, Issue 2, 2012, Pages 166-175

  Loai, Yasir ^a,b,c,d,e   Sakib, Nurus ^a,b,c,d,e   Janik, Rafal ^a,b,c,d,e   Foltz, Warren D ^a,b,c,d,e   Cheng, Hai Ling Margaret ^a,b,c,d,e  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LABELING; CELL UPTAKE; CELL VIABILITY; CONCENTRATION RANGES; CONTRAST AGENT; FIELD STRENGTHS; GADOLINIUM OXIDE; HUMAN AORTIC ENDOTHELIAL CELLS; INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROSCOPY; LABELED CELLS; MAGNETIC RESONANCE RELAXATION; RELAXIVITY;

ATOMIC EMISSION SPECTROSCOPY; BLOOD VESSEL PROSTHESES; CELLS; CYTOLOGY; INDUCTIVELY COUPLED PLASMA; MAGNETIC RESONANCE IMAGING; MUSCLE; NANOPARTICLES;

GADOLINIUM;

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM OXIDE; NANOPARTICLE; POLYLYSINE;

AORTA; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRACKING; CHEMISTRY; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; INTRACELLULAR SPACE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; SOLUTION AND SOLUBILITY; STAINING; TIME;

AORTA; CELL PROLIFERATION; CELL SURVIVAL; CELL TRACKING; CELLS, CULTURED; CONTRAST MEDIA; ENDOTHELIAL CELLS; GADOLINIUM; HUMANS; INTRACELLULAR SPACE; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; PHENOTYPE; POLYLYSINE; SOLUTIONS; SPECTROPHOTOMETRY, ATOMIC; STAINING AND LABELING; TIME FACTORS;

EID: 84860729730     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00037     Document Type: Article

References (33)

1. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-3, doi:10.1161/01.CIR.0000070931.62772.4E. (Pubitemid 36578497)
2. Hoehn M, Küstermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 2002;99:16267-72, doi:10.1073/pnas.242435499. (Pubitemid 35462784)
3. Bernas LM, Foster PJ, Rutt BK. Imaging iron-loaded mouse glioma tumors with bSSFP at 3 T. Magn Reson Med 2010;64:23-31, doi:10.1002/mrm.22210.
4. Shen J, Zhong XM, Duan XH, et al. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Acad Radiol 2009;16:1142-54, doi:10.1016/j.acra.2009.03.016.
5. Saldanha KJ, Doan RP, Ainslie KM, et al. Micrometer-sized iron oxide particle labeling of mesenchymal stem cells for magnetic resonance imaging-based monitoring of cartilage tissue engineering. Magn Reson Imaging 2011;29:40-9.
6. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol Imaging 2005;4:143-64. (Pubitemid 43143788)
7. Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol 2009;70:258-64, doi:10.1016/j.ejrad.2008.09. 021.
8. Anderson SA, Lee KK, Frank JA. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 2006;41:332-8, doi:10.1097/01.rli.0000192420.94038.9e. (Pubitemid 44406195)
9. Henning TD, Saborowski O, Golovko D, et al. Cell labeling with the positive MR contrast agent Gadofluorine M. Eur Radiol 2007; 17:1226-34, doi:10.1007/s00330-006-0522-9. (Pubitemid 46691952)
10. Tseng CL, Shih IL, Stobinski L, et al. Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging. Biomaterials 2010;31:5427-35, doi:10.1016/ j.biomaterials.2010.03.049.
11. Hsiao JK, Tsai CP, Chung TH, et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 2008;4:1445-52, doi:10.1002/smll.200701316.
12. Crich SG, Biancone L, Cantaluppi V, et al. Improved route for the visualization of stem cells labeled with a Gd-/Eu-chelate as dual (MRI and fluorescence) agent. Magn Reson Med 2004;51:938-44, doi:10.1002/mrm.20072. (Pubitemid 38580605)
13. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003;228:760-7, doi:10.1148/radiol.2283020322. (Pubitemid 37025487)
14. Engström M, Klasson A, Pedersen H, et al. High proton relaxivity for gadolinium oxide nanoparticles. MAGMA 2006;19:180-6, doi:10.1007/s10334-006- 0039-x. (Pubitemid 44438432)
15. Ahrén M, Selega°rd L, Klasson A, et al. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Langmuir 2010;26:5753-62, doi:10.1021/la903566y.
16. Klasson A, Ahrén M, Hellqvist E, et al. Positive MRI contrast enhancement in THP-1 cells with Gd2O3 nanoparticles. Contrast Media Mol Imaging 2008;3:106-11, doi:10.1002/cmmi.236.
17. Faucher L, Guay-Bégin AA, Lagueux J, et al. Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol Imaging 2010 Dec 1. [Epub ahead of print]
18. Park JY, Baek MJ, Choi ES, et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano 2009;3:3663-9, doi:10.1021/nn900761s.
19. Bridot JL, Faure AC, Laurent S, et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc 2007;129:5076-84, doi:10.1021/ja068356j. (Pubitemid 46651385)
20. Fortin MA, Petoral RM, Soderlind F, et al. Polyethylene glycolcovered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning. Nanotechnology 2007; 18:395501, doi:10.1088/0957-4484/18/39/395501. (Pubitemid 47384558)
21. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006;35:512-23, doi:10.1039/b510982p. (Pubitemid 43815285)
22. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-72, doi:10.1038/nm0603-702. (Pubitemid 36749219)
23. Montesano R, Orci L, Vassalli P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983;97:1648-52, doi:10.1083/jcb.97.5.1648. (Pubitemid 14230229)
24. van Tiel ST, Wielopolski PA, Houston GC, et al. Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells. Contrast Media Mol Imaging 2010;5:247-57, doi:10.1002/cmmi.379.
25. Lee ES, Shuter B, Chan J, et al. The use of microgel iron oxide nanoparticles in studies of magnetic resonance relaxation and endothelial progenitor cell labelling. Biomaterials 2010;31:3296-306, doi:10.1016/j. biomaterials.2010.01.037.
26. Unger EC. How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology 2003;229:615-6, doi:10.1148/radiol.2293031017. (Pubitemid 37467559)
27. Chapon C, Lemaire L, Franconi F, et al. Assessment of myocardial viability in rats: evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med 2004;52:932-6, doi:10.1002/ mrm.20210. (Pubitemid 39315001)
28. Shahbazi-Gahrouei D. Gadolinium-porphyrins: new potential magnetic resonance imaging contrast agents for melanoma detection. J Res Med Sci 2006;11:217-23. (Pubitemid 44755551)
29. Noebauer-Huhmann IM, Szomolanyi P, Juras V, et al. Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma. Invest Radiol 2010; 45:554-8, doi:10.1097/RLI.0b013e3181ebd4e3.
30. Merbach AE, Toth E. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester (NY): Wiley; 2001.
31. Hsiao JK, Tai MF, Chu HH, et al. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 2007;58:717-24, doi:10.1002/mrm.21377. (Pubitemid 47556876)
32. Heyn C, Bowen CV, Rutt BK, et al. Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med 2005;53:312-20, doi:10.1002/mrm.20356. (Pubitemid 40171045)
33. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002;17:803-11, doi:10.1006/nimg.2002.1194. (Pubitemid 35317014)